Related Experiment Video
Updated: Aug 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
A FAIR-Decide framework for pharmaceutical R&D: FAIR data cost-benefit assessment
Ebtisam Alharbi1, Rigina Skeva2, Nick Juty2
1College of Computer and Information Systems, Umm Al-Qura University, Mecca, Saudi Arabia.
Abstract:
The FAIR (findable, accessible, interoperable and reusable) principles are data management and stewardship guidelines aimed at increasing the effective use of scientific research data. Adherence to these principles in managing data assets in pharmaceutical research and development (R&D) offers pharmaceutical companies the potential to maximise the value of such assets, but the endeavour is costly and challenging. We describe the 'FAIR-Decide' framework, which aims to guide decision-making on the retrospective FAIRification of existing datasets by using business analysis techniques to estimate costs and expected benefits. This framework supports decision-making on FAIRification in the pharmaceutical R&D industry and can be integrated into a company's data management strategy.
More Related Videos
Related Concept Videos
Drug Regulation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Clinical Trials: Overview
Preclinical Development: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Discovery: Overview

